Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 08 - 25 symbols : LLY save search
Global Biopharmaceutical Markets 2021-2026 - Focus on mAB, Recombinant Growth Factors, Purified Proteins, Proteins, Hormones, Vaccines, Synthetic Immunomodulators, Enzymes, & Cell and Gene Therapies
Published: 2021-08-25 (Crawled : 20:00) - prnewswire.com
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: -0.65%
H: 0.18%
C: -0.06%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.19%
H: 0.54%
C: -0.25%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.16%
H: 0.44%
C: -0.37%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.05%
H: 0.6%
C: -1.02%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: -0.04%
H: 1.27%
C: 0.63%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.37%
H: 0.19%
C: -0.25%
biopharma gene therapies vaccine growth hormone gene therapy therapy
Innovent Announced 2021 Interim Results with Total Revenue of RMB 1,941.8 Million and Accelerated Global R&D Footprint
Published: 2021-08-25 (Crawled : 13:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.0%
H: 0.66%
C: 0.41%
results
Lilly Announces that Professor Carolyn Bertozzi has Resigned from its Board of Directors
Published: 2021-08-25 (Crawled : 11:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.0%
H: 0.66%
C: 0.41%
Lilly and Lycia Therapeutics Enter into Strategic Collaboration to Discover and Develop Novel Lysosomal Targeting Chimera (LYTAC) Degraders
Published: 2021-08-25 (Crawled : 11:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.0%
H: 0.66%
C: 0.41%
collaboration
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.